Bloomberg Markets
China’s healthcare stocks have slumped to their cheapest level ever, as a rush into local artificial intelligence beneficiaries draws capital away from defensive sectors.
Bloomberg Markets
Large private banks are trading near their cheapest levels in a decade.
Financial Times
Energy costs climb as Iran war cuts off supply through Strait of Hormuz
Bloomberg Markets
Hong Kong Financial Secretary Paul Chan said the city would attempt to “inspire the confidence” of Chinese authorities, after Beijing’s sweeping crackdown on illicit overseas investment cast a chill over banks in the city.
Bloomberg Markets
Hong Kong's Financial Secretary Paul Chan highlights the positive momentum in the city's economy. He speaks after Hong Kong recorded the fastest first-quarter growth in five years, and the IPO market remains hot. (Source: Bloomberg)
Bloomberg Markets
Chinese zinc smelters are being tested by a worsening feedstock shortage that has driven processing fees to historic lows and wiped out profits.
Bloomberg Markets
A barrage of shares is heading toward investors in India, signaling a pickup in dealmaking at the end of a subdued first half of 2026.
Bloomberg Markets
ERock Inc. raised $600 million in a US initial public offering, pricing its shares at the midpoint of its marketed range.
Bloomberg Markets
Apotex Health Corp. and some of its backers raised C$1.3 billion ($932 million) in a Toronto initial public offering, the country’s largest since 2021.
Bloomberg Markets
South Korea’s equity benchmark slipped Wednesday, with chip stocks resuming losses and risk appetite weakening following a US strike on Iran.
Yahoo Finance
Bloomberg Markets
Richard Wagner, CEO of Morgan Stanley Australia, said auction clearance rates and other metrics are "quite alarming," which may suggest a downward pressure for pockets of the property market. He spoke to Shery Ahn and Haidi Stroud-Watts on Bloomberg: The Asia Trade. (Source: Bloomberg)
Yahoo Finance
Yahoo Finance
Bloomberg Markets
Parabilis Medicines Inc., a clinical-stage cancer drug developer, raised nearly $745 million in an upsized US initial public offering that priced above its marketed range, and a private placement.
Yahoo Finance
Yahoo Finance